News in brief - Dermatology

Other new launches, licence changes and updates in dermatology.

Epimax can be used as a leave-on emollient and as a soap substitute
Epimax can be used as a leave-on emollient and as a soap substitute
  • Epimax is a new formulation of aqueous cream that does not contain the potential sensitiser sodium lauryl sulfate.
  • The cold sore cream Fenistil (penciclovir) has been reclassified from a P medicine to a GSL.
  • Meda has launched Treclin, a topical combination gel containing clindamycin 1% and tretinoin 0.025% for the treatment of moderate to severe acne vulgaris when comedones, papules and pustules are present.
  • The licence for Botox has been extended to include the treatment of moderate to severe crow's feet lines seen at maximum smile in adults, when these have an important psychological impact.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Image of both strengths of Seffalair Spiromax inhaler side by side.

New salmeterol/fluticasone dry powder inhaler for asthma

Seffalair Spiromax is the sixth dry powder salmeterol/fluticasone...

An older man in a blue shirt and beige trousers leans forward on a sofa rubbing his painful lower back. Promoted
MIMSconnect

Established muscle relaxant offers new approach to managing back pain

Sponsored by Mibe Pharma

A muscle relaxant that has been used for decades outside the UK may provide an alternative to current treatments for low back pain, explains Dr Sunny Nayee, consultant in anaesthesia and pain medicine at Imperial College NHS Healthcare Trust.

Sponsored by Mibe Pharma UK Ltd. UK/MYO/21/044; December 2021.

Click here to view prescribing information for Myopridin® (pridinol mesilate)